Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation

Coronary Artery Disease

Volumn 17, Issue 8, 2006, Pages 693-698

  Canale, Maria L ^a   Stroppa, Stefano ^a   Caravelli, Paolo ^a   Petronio, Anna S ^a   Mariotti, Rita ^a   Mariani, Mario ^a   Balbarini, Alberto ^a   Barsotti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Acute myocardial infarction with persistent ST elevation; C reactive protein; Coronary artery disease; Inflammation; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REINFARCTION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; RISK ASSESSMENT; ST SEGMENT ELEVATION;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEPHELOMETRY AND TURBIDIMETRY; PATIENT ADMISSION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 33845565314     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mca.0000236286.48812.8c     Document Type: Article

References (25)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
2. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89:36-44.
3. Mach F, Schoenbeck U, Bonnefoy JY, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by legation of CD40: induction of collagenase, stromelysin and tissue factor. Circulation 1997; 96:396-399.
4. Asakura M, Ueda Y, Yamaguchi O, Adachi T, Hirayama A, Hori M, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol 2001; 37:1284-1288.
5. Rioufol G, Finet G, Ginon D, Andre-Fouet X, Rossi R, Vialle E, et al. Multiple atherosclerotic plaque rupture in acute coronary sindrome: a -vessel intravascular ultrasound study. Circulation 2002; 106:804-808.
6. Neri Serneri GG, Abbate R, Gori AM, Attanasio M, Martini F, Giusti B, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992; 86:790-797.
7. Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti D, et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993; 88:358-363.
8. Zebrack JS, Muhlestein JB, Horne BD, Anderson JL. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 2002; 39:632-637.
9. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349:462-466.
10. Ferreiros ER, Boissonnet CP, Pizarro R, Merletti PF, Corrado G, Cagide A, et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 1999; 100:1958-1963.
11. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331:417-424.
12. de Winter RJ, Bholasingh R, Lijmer JG, Koster RW, Gorgels SP, Schouten Y, et al. Independent prognostic value of C-reactive protein and troponin I in patient with unstable angina or non-Q-wave myocardial infarction. Cardiovasc Res 1999; 100:1958-1963.
13. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973-979.
14. Boekholdt SM, Hack CE, Sandhu MS, Luben R, Bingham SA, Wareham NS, et al. C-reactive protein levels and coronary artery disease incidence and mortality in apparently health men and women: the EPIC-Norfolk prospective population study 1993-2003. Atherosclerosis published online first: 27 October 2005, doi: 10.1016/j.atherosclerosis.2005.09.023.
15. Mariotti R, Musumeci G, De Carlo M, Biadi O, Caravelli P, Limbruno U, et al. Acute-phase reactants in acute myocardial infarction: impact on 5-year prognosis. Ital Heart J 2001; 2:294-300.
16. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21:1502-1513.
17. (Also published in J Am Coll Cardiol 2000;36:959-969).
18. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green CA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). 2004. Available at www.acc.org/clinical/guidelines/stemi/index.pdf.
19. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22:6A.
20. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
21. Kwaijtaal M, van Diest R, Bar FW, van der Ven AJ, Bruggeman CA, De Baets MH, et al. Inflammatory markers predict late cardiac events in patients who are exhausted after percutaneous coronary intervention. Atherosclerosis 2005; 182:341-348.
22. Jahn J, Hellmann I, Maass M, Giannitis E, Dalhoff K, Katus HA. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome. Herz 2004; 29:795-801.
23. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt KW, Wolbink GS, et al. C-reactive protein as a cardiovascular risk factor. More than an epiphenomenon? Circulation 1999; 100:96-102.
24. Hoffmeister A, Rothenbacher D, Kunze M, Brenner H, Koenig W. Prognostic value of inflammatory markers alone and in combination with blood lipids in patients with stable coronary artery disease. Eur J Intern Med 2005; 16:47-52.
25. Janoskuti L, Forhecz Z, Hosszufalusi N, Kleiber H, Walentin S, Balint O, et al. High levels of C-reactive protein with low cholesterol concentrations additively predict all-cause mortality in patients with coronary artery disease. Eur J Clin Invest 2005; 35:104-111.